NEW YORK (GenomeWeb) – ChromaCode expects to fill an unmet need in the diagnostics market with a new molecular assay to test for common tick-borne pathogens. The firm launched a nine-target, research-use-only, qPCR panel test today that can detect a total of 12 species that are typically transmitted to humans by ticks in various regions of the US.
Get the full story with
360Dx Premium
Only $95 for the
first 90 days*
360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a 360Dx or GenomeWeb Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.